Recent Updates
Recently added Catalysts

OMS201

Phase 1

Urinary Calculi | Small molecule | Nephrology |Omeros Corporation|Last Updated: Oct 12, 2012

Success Probability
Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
Premium
Market & Valuation
rNPV $3.2B
Market Size $9.4B
Revenue Basis $1.6B
Competitors 6
Premium
Trial Design
RandomizedDouble-BlindPLACEBO_CONTROLLEDBiomarker
Total Trials2
Total Enrollment29
FDA Designations
No designations recorded
Clinical Trials (2)
NCT IDTitlePhaseStatusEnrollmentVelocityDesignStartCompletionLast UpdatedSitesCountries
NCT00857090Pharmacokinetic, Safety and Efficacy Study of OMS201 in Subjects Undergoing Retrograde Ureteroscopic Removal of Upper Urinary Tract StonesPHASE1 COMPLETED 18Mar 1, 2009Dec 1, 2010Oct 12, 20124 United States
NCT00599664Pharmacokinetic and Safety Study of OMS201 in Subjects Undergoing Ureteroscopic Treatment for Removal of Urinary Tract-Located StonesPHASE1 COMPLETED 11Dec 1, 2007Sep 1, 2008Apr 30, 20102 United States
Unlock Drug Trial Details
Study Endpoints
Primary Endpoints
Peak systemic exposure.
Day of surgery
Pharmacokinetic
Day of Surgery
Secondary Endpoints
Safety
Day 7
Degree of pain
7 days
Duration of the operation
Day of surgery
Unlock Study Endpoints
Study Design & Arms
AllocationRANDOMIZED
MaskingTRIPLE
ModelPARALLEL
PurposeTREATMENT
Treatment Arms
ArmTypeDescription
1EXPERIMENTALDrug
2PLACEBO_COMPARATORVehicle
Interventions
NameTypeDescription
OMS201DRUGStage 1: OMS201 irrigation solution at 3X the base concentration during surgery Stage 2: OMS201 irrigation solution up to 10X the base concentration during surgery
VehicleDRUGStages 1-2: Vehicle irrigation solution during surgery
Unlock Study Design Details
Eligibility Criteria
Age Range18 Years — 65 Years
SexALL
Healthy VolunteersNo
Study Sites4

Inclusion Criteria: * 18 - 65 years of age. * Subject is undergoing retrograde ureteroscopic removal of renal-collecting system or ureteral stones for which general anesthesia will be used. Exclusion Criteria: * No allergies to any of the individual ingredients in OMS201. * Subject taking a prohi...

Countries:United States
Unlock Eligibility Criteria